Advertisement

X

Party Drug Ketamine Offers Rapid Relief From Chronic Depression

by VR Sreeraman on  October 06, 2012 at 4:55 PM Mental Health News   - G J E 4
A -A +
Researchers have found a clue on how small amount of the drug ketamine offers immediate relief for patients who are chronically depressed and for those who are resistant to treatments.

The ability of the drug was first observed at Yale University.
 Party Drug Ketamine Offers Rapid Relief From Chronic Depression
Party Drug Ketamine Offers Rapid Relief From Chronic Depression

A review of scientific research written by Yale School of Medicine researchers has provided evidence suggesting that the pediatric anesthetic helps regenerate synaptic connections between brain cells damaged by stress and depression.

Ketamine works on an entirely different type of neurotransmitter system than current antidepressants, which can take months to improve symptoms of depression and do not work at all for one out of every three patients.

Understanding how ketamine works in the brain could lead to the development of an entirely new class of antidepressants, offering relief for tens of millions of people suffering from chronic depression.

"The rapid therapeutic response of ketamine in treatment-resistant patients is the biggest breakthrough in depression research in a half century," said Ronald Duman, Elizabeth Mears and House Jameson Professor of Psychiatry and Professor of Neurobiology.

Duman and George K. Aghajanian, also professor of psychiatry at Yale, are co-authors of the review.

Understanding how ketamine works is crucial because of the drug's limitations. The improvement in symptoms, which are evident just hours after ketamine is administered, lasts only a week to 10 days. In large doses, ketamine can cause short-term symptoms of psychosis and is abused as the party drug "Special K."

In their research, Duman and others show that in a series of steps ketamine triggers release of neurotransmitter glutamate, which in turn stimulates growth of synapses. Research at Yale has shown that damage of these synaptic connections caused by chronic stress is rapidly reversed by a single dose of ketamine.

The original link between ketamine and relief of depression was made at the Connecticut Mental Health Center in New Haven by John Krystal, chair of the department of psychiatry at Yale, and Dennis Charney, now dean of Mt. Sinai School of Medicine, who helped launch clinical trials of ketamine while at the National Institute of Mental Health.

Efforts to develop drugs that replicate the effects of ketamine have produced some promising results, but they do not act as quickly as ketamine. Researchers are investigating alternatives they hope can duplicate the efficacy and rapid response of ketamine.

The review was published in the latest issue of the journal Science.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

Most Popular News on Medindia

P
M
X

Ask an Expert

Ask an Expert+
s
Using Benzodiazepines Raises Dementia Risk Among ...
 Using Benzodiazepines Raises Dementia Risk Among Elderly
S  HIV Tied To Rise in Anal Cancer in US Males
HIV Tied To Rise in Anal Cancer in US Males